Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

2 hrs ago | ABC News

China to Put Glaxo Investigators on Trial Aug. 8

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.


Related Topix: GlaxoSmithKline

3 hrs ago | The Modesto Bee

$1,000 pill now hepatitis C treatment of choice

In less than six months, prescriptions for Sovaldi have eclipsed all other hepatitis C pills combined, according to new data from IMS Health.


Related Topix: Hepatitis, Medicine, Health, Gilead Sciences, Healthcare Industry, Startups, Health Insurance, Medicaid, Woody, CA

Mon Jul 28, 2014

Wall Street Journal

Wanted: Startups in Biotech

The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.


Related Topix: Science / Technology, Pfizer, Medicine, Healthcare Industry, Eli Lilly, Opinion

News Times

Biodel, Lincoln Park enter into $15 million equity deal

A Danbury company researching better ways to treat diabetes has expanded its funding sources through a stock sale agreement with an investment firm.


Related Topix: Biodel, Medicine, Diabetes, Health, Food and Drug Administration

Business Journal

Targacept misses again - overactive bladder treatment fails in trial

Targacept CEO Dr. Stephen Hill says the company is considering how best to make use of its resources after the latest in a string of clinical trial failures.


Related Topix: Medicine, Targacept, Healthcare Industry, Overactive Bladder


9 of the world's most beautiful piers

Italy's Rotonda a Mare was built in 1923 but closed in 2005 for renovations. It reopened a year later, with a beautiful sea-themed mosaic by Enzo Cucchi adorning the entrance.


Related Topix: Enzo Biochem, Medicine, Healthcare Industry, California, California Government, Travel

USA Today

Got a spider bite? Most of the time no need to panic

An increase in spider-bite patients at Vanderbilt University Medical Center here has created some concern - but not about an influx of brown recluse spiders in garages or bathroom cabinets.


Related Topix: Vanderbilt University, Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Illinois, Entomology, Science

The Independent

Broken up? GlaxoSmithKline's real problem is getting eaten up by scandal

Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.


Related Topix: GlaxoSmithKline, US News

USA Today

Pay up! The companies charging you more

Inflation is mild? That's what the government says, but investors paying attention to earnings calls are hearing something they haven't heard in a awhile: Some bold companies are raising prices.


Related Topix: Philip Morris International, Tobacco, Allergan

Seeking Alpha

Investment Advice From The Federal Reserve: Unusual, Unwise And Unseemly

On July 15, Janet Yellen made news with her semiannual policy testimony to Congress, with her views on interest rates, bubbles and the debt market.


Related Topix: Financial Markets, Science / Technology, Startups, Facebook, Advertising

West Australian

Pfizer's need for deal looms larger with earnings report

While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, some say the U.S. drugmaker should consider targets more focussed on biotechnology, a strategy that has paid off for Merck & Co Although Pfizer is conducting trials of promising products - including breast cancer drug palbociclib and vaccines ... (more)


Related Topix: Merck , Medicine, Healthcare Industry, Health, Breast Cancer, Cancer

Sun Jul 27, 2014

DNA India

Wockhardt's plant may soon get out of regulatory woes

Wockhardt Ltd, which denied stake-sale rumours on Friday following an unusual spurt in its stock price, is in the final stages of receiving much-awaited regulatory approvals for its Chikalthana unit in Maharashtra.


Related Topix: Wockhardt, Food and Drug Administration, World News, India,

The Olympian

How will we pay for a $300,000 drug?

Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.


Related Topix: Vertex, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Cystic Fibrosis, Health, Fibrosis, Genetics, Healthcare Law, Law

KVBC-TV Las Vegas

Trial in salmonella outbreak to start in Georgia

Three people accused of scheming to manufacture and ship salmonella-tainted peanuts that killed nine people and sickened more than 700 are set to go to trial this week in Georgia.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

Kenya Broadcasting Corporation

Merck introduces e-learning courses for medical students, professionals

Merck has kicked off its second year of its five year project to provide European Accredited Clinical Diabetes Management course for medical and pharmacy students in African Universities by introducing E-Learning.


Related Topix: Merck , Medicine, Healthcare Industry

New Scientist

Genetic moderation is needed to debate our food future

GM is now a term loaded with baggage. Scientists must allow for people's objections to show the public there's nothing "spooky" about it WITH food security firmly on the international agenda, there's a growing appetite to look again at the opportunities promised by agricultural biotechnology.


Related Topix: Genetics, Medicine, Agriculture, Science, Science / Technology

News Observer

Summer of sequencing genomes

The second, accepted but not yet published by Theoretical and Applied Genetics, was done with several of the professional scientists mentoring the P2EP interns.


Related Topix: Genetics, Medicine, Biology, Science, Winston-Salem, NC, Science / Technology, Bioinformatics

Sat Jul 26, 2014

Medical News

EGPAF applauds new licensing agreement to improve access to HIV medication for children

The Elizabeth Glaser Pediatric AIDS Foundation applauds the new licensing agreement between the Medicines Patent Pool and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate , a promising new HIV medication.


Related Topix: HIV/AIDS, Health, Medicine, Gilead Sciences, Healthcare Industry, Australia, World News,

WTVG-TV Toledo

Lou Gehrig's disease is rare, 1st US count finds

The government has issued its first national estimate for Lou Gehrig's disease, confirming the devastating disease is rare.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

The Globe and Mail

Why Janet Yellen is wrong about biotech and social media

In this , Tuesday, Feb. 11, 2014, file photo, Federal Reserve Chair Janet Yellen listens while testifying on Capitol Hill in Washington.


Related Topix: Science / Technology, Financial Markets


Biotech Jobs